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Background: Low back pain (LBP) and fibromyalgia (FM), also known as chronic widespread 
pain (CWP), are highly prevalent chronic painful conditions that have substantial impact on 
patients, health care systems, and society. Diagnosis is complex and management strategies 
are associated with various levels of evidence for effectiveness and cost-effectiveness. Multi-
disciplinary pain services have been shown to be effective in some settings and therefore are 
recommended by clinical practice guidelines as a rational treatment option to manage these 
patients. Knowing that these services are resource intensive, evidence is needed to demonstrate 
their cost-effectiveness. This study aims to describe the management of patients with LBP 
and FM in two community pain clinics to derive an indicative estimate of cost-effectiveness 
 compared with standard practice.
Methods: This is a prospective observational multicenter study, using patient-level data. The 
data from this study will be combined with modelling of the long-term economic impact of 
community pain clinics in treating people with LBP and FM. Newly referred patients with 
LBP and FM who provide written consent will be included. We will collect data on functional 
disability, pain intensity, quality of life, and health resource utilization. Follow-up data at the 
3- and 6-month points will be collected by patient-completed questionnaires and health care 
contact diaries. Health care resource use from diaries will be compared with patient electronic 
records to assess the agreement between these recording methods. Patient cohort characteristics, 
treatment pathways, resource use, and outcomes derived from this study will be integrated in 
a decision analysis model to assess the cost-effectiveness of community pain clinics compared 
with standard care. This feasibility study will address key methodological issues such as sample 
estimates and retention rate to inform the design of a future randomized controlled trial.
Keywords: community pain clinics, back pain, fibromyalgia, cost-effectiveness
Introduction
Low back pain (LBP) and fibromyalgia (FM), which is also known as chronic wide-
spread pain (CWP), are highly prevalent worldwide,1,2 affecting 9.4% and 2.7% of the 
general population, respectively.3,4 Both conditions have substantial effects on physi-
cal function, psychological well-being, and quality of life.5–10 According to the global 
burden of disease study in 2010,11 back pain was the leading cause of years lived with 
disability and the third leading cause of disability adjusted life years (DALYs) after 
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ischemic heart disease and chronic obstructive pulmonary 
disease.
The economic burden of both conditions is also sub-
stantial. People with these conditions are regarded as great 
utilizers of health care resources.12–15 Recently, it has been 
reported that health resource utilization such as prescriptions 
and visits for patients with back pain and FM were double 
those of the matched controls.14,15 In the United Kingdom,15 
primary care consultations and referral to secondary care for 
LBP accounted for 58% and 22.3% of the total health care 
costs for back pain, respectively. Furthermore, indirect costs 
to society are significant, due to lower productivity and higher 
absenteeism.16,17
Managing these conditions is challenging due to many 
factors. First, the etiology is complex and not specific.18–20 
Also, they can be exacerbated by a wide range of sociode-
mographic and psychosocial factors such as illness behavior 
beliefs and distress.18,21,22 Therefore, no single treatment is 
adequate to control all symptoms.
In order to manage pain within a biopsychosocial 
framework, which addresses pain as a dynamic interaction 
between physiological, social, and psychological elements, 
a multidisciplinary management approach is recommended 
by national and international guidelines.21,23–25 Effectiveness 
of the multidisciplinary management approach has been 
widely investigated in LBP and FM.
In LBP, a systematic review of randomized controlled 
trials suggested that multidisciplinary pain services are more 
effective than standard care (SC) in reducing functional 
disability using the Roland Morris Disability (RMD) score 
(standardized mean difference [SMD]: 0.23, 95% confidence 
interval [CI]: 0.06–0.4) and pain intensity using visual ana-
logue scale (VAS) (SMD: 0.21, 95% CI: 0.04–0.37).26 In 
2008, results from a systematic review indicated that multi-
disciplinary pain services were better than standard medical 
treatment in FM.27 However, results are inconclusive due 
to the great variability of the interventions, outcomes, and 
study durations. The major limitation with these systematic 
reviews is that the methodological quality of most studies 
included was low.
Given that multidisciplinary pain services are resource 
intensive;28,29 evidence is needed to demonstrate the cost-
effectiveness of these services in LBP and FM. A small 
number of cost-effectiveness studies have been undertaken 
in Europe and the USA,30–40 others are still in progress in 
Spain and the Netherlands.41,42 These studies were conducted 
alongside clinical trials; however, they have methodological 
limitations in study design. Compliance to treatment was 
either inadequate32,33,35,36,38–40 or not clearly reported.30,31,37 
Moreover, some aspects of treatments/sessions did not appear 
to be equally used by all participants.32,34,36,38 Therefore, the 
effect cannot be directly attributed to multidisciplinary pain 
service.
In addition, threats to external validity may impede the 
application of the results to real practice.43 These threats 
come from restrictive patient eligibility criteria such as 
employees,30,33 recruiting from various practice settings, 
ie, primary and secondary care setting, and variability of 
intervention. This variability is either between intervention 
in terms of treatment components and health care staff or 
between study participants.
Among these studies, a wide range of comparators were 
used such as surgery36,37 physiotherapy/exercise,32,39,40 and 
cognitive behavioral therapy.32,34,39,40 Six studies compared 
multidisciplinary pain service with usual care.30,31,33,38–40 The 
definition of usual care varies according to the country and 
study context, this will also limit the applicability of results. 
Therefore, results about the cost-effectiveness of these 
services have been inconclusive because of the variety of 
interventions, participants, and outcome measures.
Community pain clinic in 
Nottingham
The project will take place in two community pain clinics 
(CPC) in Nottingham, UK. These two clinics are operated by 
the same clinic staff, therefore, the type and quality of health 
care provided are the same in both clinics. Patients may have 
consultations with members of the multidisciplinary team 
(including a pain consultant, a physiotherapist, a biopsy-
chosocial practitioner, and a nurse) for supported self-care 
management, or community services such as physiotherapy, 
or more specialist secondary care services. The community 
pain clinic facilitates access to a wide range of diagnostic and 
treatment pathways such as MRI, rehabilitation programs, 
and minor procedures such as trigger point injections. In addi-
tion, complex surgical interventions can be offered. Further 
details on the community pain clinic in Nottingham can be 
found in the review by Hobbs and Knaggs.44
LBP and FM represent the majority of patients referred 
to the clinic, therefore these conditions will be the main 
focus of this study.
Before establishing the CPC, patients with LBP and 
FM were treated initially by their GPs. If treatment failed 
to improve patients’ outcomes, then referrals to secondary 
care may have been considered. This SC pathway may lead 
to increased rates of development of chronic pain due to the 
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Intervention
outcomes and cost:
current observational
study 
Comparator outcomes
and cost:
published literature
Indicative economic
evaluation   
Figure 1 overall study design.
delay in diagnosis and treatment and the long  waiting time to 
be referred to secondary care.45–47 Alongside the detrimental 
effects of treatment delay, there appears to be a high level of 
inappropriate spinal surgery unit referrals, suggesting that 
more targeted use of this service is needed.48
Anecdotally, impressions are that patients are benefiting 
from the CPC and if it were expanded, patients in the local-
ity would benefit from better pain management. However, 
financial constraints prevent the possibility of expanding, 
or even continuity, of the current service. Evidence so far 
suggests that multidisciplinary pain clinics can be effective, 
although the effectiveness of the Nottingham CPC is not 
known. Given that it is likely that these types of services are 
highly costly and require integration between health care 
sectors, the effectiveness, patient acceptability, and cost-
effectiveness of CPCs needs to be investigated.
Electronic administrative records can be used to estimate 
health resource use. It reduces data recording burden for 
patients, and generally provides more detail about types 
of health care contacts. However, the data can be time-
 consuming to access, and may only be reliable and com-
plete for a specific sector (eg, hospital stays are not always 
recorded reliably in GP recording systems49). In addition, in 
the  management of LBP, we envisage that people will use 
other treatments maybe outside the NHS, such as private oste-
opathy and physiotherapy. Patient diaries allow us to capture 
that patient cost. Therefore, in this observational study, we 
will use both methods to capture resource use data to allow 
us to assess which method is more reliable for future work 
in this patient group.
Commissioners and decision makers need support to 
make decisions about service provision, so waiting for the 
full evaluative trial to be completed will not produce timely 
evidence to support decision-making. It has long been recog-
nized that economic evaluation should be iterative, generating 
progressively firmer estimates of cost-effectiveness and help-
ing to maximize the efficiency of health care research and 
development, while still allowing the best evidence available 
at any one time to support decision-making.50 Therefore an 
indicative economic evaluation will be carried out to compare 
the cost-effectiveness of CPC and SC in managing LBP and 
FM using published estimates of effectiveness and cost.
The paucity of economic evaluations of multidisciplinary 
pain management services and the variable levels of evidence 
underpinning the effectiveness of these services suggest that 
cost-effectiveness studies need be conducted before this 
model of care is more widely implemented. Therefore, the 
aim of this study is to carry out an evaluation of the CPC in 
Nottingham to inform decision-makers and commissioners 
about the effectiveness and cost-effectiveness of this service 
and, therefore, allocating resources in an efficient manner.
Specific objectives are to:
1. Describe the demographic characteristics of patients with 
LBP and FM and their treatment pathway in the CPC.
2. Determine clinical outcomes and health care costs of 
the CPC using patient reported outcome measures and 
routinely recorded health care resource use.
3. Assess the reconciliation between patient-reported and 
routinely recorded health care resource use data and 
derive cost estimations by combining the two methods.
4. Derive indicative estimates of cost-effectiveness of CPC 
compared with SC in managing LBP and FM combining 
data from this study with published estimates of effec-
tiveness for multidisciplinary pain clinics and long-term 
costs and outcomes associated with LBP and FM.
5. Inform the design of a future cluster randomized trial 
to evaluate the effectiveness and cost-effectiveness of 
CPC.
Methods
Study design
This is a prospective observational multicenter study, using 
patient-level data. The data from this study will be combined 
with modelling of the long-term economic impact of com-
munity pain clinics in treating people with LBP and FM. The 
study design is summarized in Figure 1.
Study setting
The study will be conducted at the Nottinghamshire primary–
secondary care interface. Newly referred patients to Not-
tingham West Clinical Commissioning Group and Newark 
and Sherwood CCGs who fit the eligibility criteria will be 
invited. Recruiting from two clinics will increase the number 
of participants, and therefore the study will be powered to 
detect difference in primary outcomes.
Sample size and justification
This is not an interventional study; so, a sample size is 
not required to derive an effect size. However, the sample 
obtained in this study will provide data to inform a future 
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Table 1 Summary of collected data
Stage Outcome measure Time point recorded Method of recording
observational study  
(stage 1)
Patients characteristics Baseline Questionnaire completed 
by telephone call
Disease specific outcome measure: 
•  Fibromyalgia: the revised Symptoms Impact Questionnaire
•  Back pain: roland Morris disability Questionnaire
Baseline, 3 months, and  
6 months
Pain intensity and interference: 
Brief Pain Inventory
Baseline, 3 months, and  
6 months
Health status:  
EuroQol-5 dimension-3 level instrument
Baseline, 3 months, and  
6 months
Health care resource use 3 and 6 months post referral Self-completed diary
costing method  
comparative study 
(stage 2)
Health care resource use 0–6 months inclusive Patients’ medical record
sample size calculation. The largest sample possible is also 
required to provide richer information about the patient 
cohort using CPC for LBP and FM.
Ethical approval
Ethical approval for the study has been obtained from North 
East York and East Midland-Nottingham 1 Research Ethics 
Committees (REC reference numbers 15/NE/0162 and 15/
EM/0190).
Inclusion criteria
1. Adults (18 years or older), attending the pain clinic for the 
first time and who have LBP or FM for at least 3 months.
2. Participants will be required to have good understanding 
of the English language and the ability to understand 
study documents and provide written consent.
As this study will include patients with different disease 
states, the exclusion criteria for each condition is listed 
below:
Exclusion criteria for people with low back pain
1. Having an underlying organic pathology for low back 
pain such as infection or cancer.
2. Having had a spinal surgical procedure in the past 6 weeks 
or having to undergo surgery within 3 months.
3. Having severe psychiatric disorders such as major depres-
sion or psychosis.
4. Being pregnant or having given birth in the past 3 months.
Exclusion criteria for people with fibromyalgia
1. Not having a confirmed diagnosis of FM.
2. Having severe psychiatric disorders such as major depres-
sion or psychosis.
outcome measures
Disease-specific outcome measures will be used for each 
disease group population. Roland Morris Disability Ques-
tionnaire51 will be used to assess the functional disability for 
patients with LBP and to assess the functionality of patients 
with FM the Revised Symptoms Impact Questionnaire 
(SIQR)52 will be used.
Pain intensity will be measured using the short-form Brief 
Pain Inventory (BPI),53 whereas health status will be assessed 
by EuroQol-5 Dimension-3 level instrument (EQ-5D-3L).54 
A summary of the outcome measures recorded during the 
study is provided in Table 1.
Study regimen
This study will involve three main stages. For each stage, 
the aim, methodological features, outcome measures or data 
collected, and duration are described below.
Stage 1: observational study – assess the clinical 
outcomes and health care use in cPc
The pain clinic consultant will have the responsibility of 
identifying eligible patients at triage.44 The initial patient 
approach will be from the pain clinic consultant, who will 
inform the participant of all aspects pertaining to participa-
tion in the study.
The questionnaires will be piloted using a small number of 
patients (approximately 5–10 patients) attending the two CPCs 
to examine the type, accuracy, and practicality of resource use 
data collection tools and outcome measure tools.55 These patients 
will be included in the final analysis if no further amendments 
to the study design or data collection tools are made.
This pilot study will follow the same procedure of the 
main study in terms of identification, recruitment, and contact 
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Table 2 data sources for economic models
Outcomes and costs Short term Long term
Intervention current observational  
study
Economic evaluation 
alongside observational 
longitudinal studies
comparator Economic evaluation 
alongside randomized 
clinical trials
method. The main study will follow the procedure detailed: 
The pain clinic consultant will identify and invite eligible 
patients to take part in the study and will explain the study 
to the eligible patient. If the patient has initially expressed 
interest in being involved in the study, the consultant will pro-
vide the patient with the study information pack. The patient 
will be asked to provide his/her contact details by clinic 
staff to arrange a telephone call with the researcher within 
24–72 hours to allow the patient to consider participation in 
the study. To maximize retention of the study participants, 
each patient will determine the preferred time slot of the day 
for researcher to contact him/her.
Within 24–72 hours of the initial patient encounter, the 
researcher will contact the patient to confirm the consent 
and answer any questions related to the study. The patient 
will need to sign the consent form and send it back to the 
researcher by post.
The patient will be asked to answer questions related 
to his/her baseline pain, physical function, and health 
status. In addition, demographic data of patients will be 
obtained. The researcher will contact the patient by phone 
to collect clinical outcome data after 3 and 6 months. 
Patients will be encouraged to record their health resource 
use using diaries. These diaries will be returned by post 
at 3 and 6 months.
Stage 2: assess the agreement between patients’  
self-reported health resource use and medical 
records in cPc
This stage aims to assess health care utilization data col-
lection methods, when resource use data are obtained from 
either medical records or patient self-report using a diary, by 
assessing the reconciliation between these two approaches 
and resulting cost estimations derived from the resource use 
data obtained. Health care resource use data from the previ-
ous stage, using patient-reported methods, will be compared 
with health care resource data elicited from medical records 
of CPC patients.
These data will be collected retrospectively for 6 months 
from the date of CPC referral. A data analyst will extract the 
data required. Data extracted will include medication use and 
primary and secondary health care service use;  principally 
GP visits, emergency department visits,  inpatient,  outpatient 
attendances, and other community services (ie, physio-
therapy). The data will be extracted from GP practices 
that use SystmOne56 and EMIS57 to record patients’ data 
electronically.
Stage 3: indicative economic evaluation
Data collected from the study will be used to inform an 
indicative economic evaluation. Cost-effectiveness will be 
investigated by generating differences in costs and outcomes 
between SC and CPC. Published evidence on costs and out-
comes for SC will be combined with outcomes and costs from 
the patient cohort in this study to generate mean incremental 
quality adjusted life years (QALY) and costs. The data will 
be gathered from participants for 6 months. The costs and 
 benefits of CPC will be calculated over a 6-month period (short 
term). The long-term (5–10 years) costs and outcomes will be 
estimated using decision analysis modelling. This period will 
be sufficient to observe the effect of intervention on costs and 
outcomes;58 therefore, two models will be constructed. The data 
sources for the two models are illustrated in Table 2.
The costs will be collected from health provider perspec-
tive. Intervention cost will be calculated using a “bottom–up” 
approach. Patients’ visits to CPC and the types of treatments 
received will be gathered from the medical records. Direct 
medical cost such as visits to GP, nurses, other health care 
professionals, and hospitals will be recorded in costing diary. 
Direct nonmedical costs such as travel expenses will be also 
recorded in costing diary. These diaries will be administered 
twice during the study (3 months period).
Direct health care costs will be obtained from the following 
sources: costs of treatment interventions and investigations will 
be derived from NHS reference costs,59 costs of health staff 
from the Personal Social Services Research Unit (PSSRU),60 
and medication costs from the British National Formulary61 
(March–September 2015). All costs will be expressed in 
2015–2016 pounds sterling. The discount will be applied in 
the long-term model only; we will discount effects and costs at 
an annual rate of 3.5%. The UK Treasury recommended 3.5% 
discount rate for both costs and outcomes.62 In addition, differ-
ent discount rates will be tested in the sensitivity analysis.
Short term
We will conduct a short-term (6 months) cost-effectiveness 
decision analysis model from NHS perspective. Markov 
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model inputs will be based on the data derived from the 
current observational study and published literature. The 
short-term effect of SC on outcomes and cost will be obtained 
by conducting a systematic review of cost-effectiveness 
studies of multidisciplinary pain management services in 
LBP and FM.
long term
The long-term benefit of multidisciplinary pain manage-
ment services needs to be evaluated as these services are 
cost intensive. Moreover, little is known about the long-term 
effectiveness. Therefore, the model input will be based on 
data from published literature. Longitudinal observational 
studies which aim to evaluate the effectiveness and cost-
effectiveness of multidisciplinary pain management services 
in LBP and FM will be used. The data source for the models 
is illustrated in Table 2.
Analyses
Stage 1: observational study
We will describe the study population and their outcomes 
using simple descriptive statistics, percentages for categori-
cal, and mean and SD for continuous variables.
Changes within outcome measures over the duration of 
the study will be assessed using paired t-tests for continuous 
data and McNemar tests for dichotomous data.
Unit costs will be combined with resource-use from the 
two collection methods to generate two estimates of patient-
level costs.
We will determine baseline factors associated with change 
of outcome measures or cost over the course of patient 
follow-up. This will be performed using multiple linear and 
logistic regression for continuous and binary outcome vari-
ables, respectively. P-values less than 0.05 will be considered 
statistically significant.
Stage 2: costing methods comparative 
study
Nonparametric bootstrapping will be used to compare arith-
metic means of costs data.63 Pairwise t-tests will be applied 
to the data generated by bootstrapping. Level of agreement 
between electronic and self-reported resource-use will be 
estimated by using the Lin concordance correlation coef-
ficient,64 which can be applied to nonnormally distributed 
data such as resource use data. The Lin coefficient value lies 
between 1, indicative of perfect agreement, and –1, indicative 
of perfect inverse agreement.
Stage 3: indicative economic evaluation
This economic study will be performed according to the 
 intention-to-treat principles. For missing data during 
 follow-up, we will use complete case analysis.
We will carry out incremental analysis, which is mean dif-
ference in cost between CPC and SC divided by the mean in 
QALY difference to generate incremental cost-effectiveness 
ratio (ICER). Nonparametric bootstrapping with 1,000 itera-
tions will be used to calculate the confidence interval around 
the ICER and cost difference.
To assess the robustness of the results, deterministic 
univariate and multivariate sensitivity analyses will be 
performed. Probabilistic sensitivity analysis (PSA) will be 
undertaken for base-case scenario and univariate and multi-
variate analysis. Sampling incremental costs and QALY will 
be conducted by Monte Carlo simulation using TreeAge Pro. 
We will use cost-effectiveness planes and cost-effectiveness 
acceptability curves (CEACs) to present the results. All statis-
tical analyses will be conducted using STATA 11.1.65 TreeAge 
Pro66 will be used to build the decision analysis model.
Discussion
The major strengths in this study design are that we will use 
validated gold standard measures for each of these patient 
outcomes to assess which best reflects the success and accept-
ability of the service from the patient perspective. We also 
need to obtain detailed information on treatment pathways. 
This is essential to understand the nature and variability of the 
complex intervention. It is also needed to allow us to estimate 
resource use and cost, associated with managing patients by 
the CPC. Treatment pathway and associated resource use data 
can be obtained either by accessing routine medical records, 
or by patient report. Neither method is without its limitations. 
In this study, we will use both methods to capture resource 
use data to allow us to assess which method is more reliable 
for future work in this patient group.
Moreover, the choice of study design was based on the 
Medical Research Council (MRC) recommendation for 
evaluating complex intervention. Multidisciplinary pain clin-
ics such as the Nottingham CPC are considered as “complex” 
interventions. This complexity is derived by the number 
of interacting components within the clinic and variety of 
intended outcomes. There are known difficulties and method-
ological challenges in evaluating complex interventions. The 
MRC published a framework which recommends evaluating 
the intervention through observational and developmental 
work, followed by an exploratory trial before conducting 
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the definitive evaluation. This is required to identify key 
uncertainties in the design and assessment of the intervention 
and its evaluation.67
Recruitment and retention rates are major limitations 
on any prospective study design. In this study, several data 
collection methods were considered, such as postal question-
naires, face-to-face interviews, and phone calls. However, 
there are some practical difficulties in using interviews, 
as patients may be referred to other health care specialists 
outside the clinic during the study period. For postal ques-
tionnaires, there is a risk of low response rate. Given that the 
study period is relatively short (6 months), telephone calls 
were chosen for data collection over other methods to maxi-
mize the response rate and to facilitate patient tracking. In 
addition, each patient will determine the preferred time slot 
of the day for researcher to contact him/her. If the patients did 
not respond to the first phone call, the researcher will contact 
the patient twice within 1 hour. The total number of calls will 
be three times, each is 20 minutes apart. Another attempt will 
be made on the following day in case of no response. Further-
more, the patient will be approached by letter to re-establish 
the contact. Participants who do not respond to phone calls 
after these attempts will be presumed to have withdrawn from 
the study and no further contact will be made.
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